https://de.marketscreener.com/kurs/aktie/NEUROCRINE-BIOSCIENCES-IN-10163/news/Neurocrine-Biosciences-Inc-meldet-positive-Phase-2-Daten-fur-NBI-1065845-bei-Erwachsenen-mit-schw-46503879/?utm_source=telegram&utm_medium=social&utm_campaign=share